These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis.
    Author: Caminati A, Bianchi A, Cassandro R, Mirenda MR, Harari S.
    Journal: Respir Med; 2009 Jan; 103(1):117-23. PubMed ID: 18786822.
    Abstract:
    BACKGROUND AND AIM OF THE WORK: Idiopathic pulmonary fibrosis (IPF) is a progressive disease with high mortality rates and a median survival of 2-3 years from time of diagnosis. The prognosis for any individual patient, however, is variable. To elucidate the clinical significance of 6-min walking test (6-MWT) in patients with IPF, we sought to assess the relationship between distance walked and desaturation during this test and pulmonary function tests (PFTs). We also evaluate the prognostic value of 6-MWT in comparison with PFTs at baseline and during follow-up. METHODS: The clinical data of 44 patients with IPF were retrospectively analysed. Twenty-nine patients had an additional evaluation after 12 month of follow-up. RESULTS: Distance walked in 6 min was independently related to mortality by multivariate analysis. Patients walking less then 212 m had a significantly lower survival than those walking farther, assessed by Kaplan-Meier survival curves (log-rank test, p<0.036). During a mean follow-up period of 19.8 months (range 3.2-46.4), 11 patients died of causes related to disease. Changes in meters walked at 12 months evaluation were also predictive of survival (p=0.05). CONCLUSIONS: These results confirm that in IPF distance walked in 6 min is independent associated with mortality.
    [Abstract] [Full Text] [Related] [New Search]